Abstract
See also van den Boogaard FE, Brands X, Schultz MJ, Levi M, Roelofs JJTH, van 't Veer C, van der Poll T. Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia. This issue, pp 122-32.
© 2010 International Society on Thrombosis and Haemostasis.
MeSH terms
-
Animals
-
Anti-Infective Agents / therapeutic use*
-
Anti-Inflammatory Agents / therapeutic use
-
Anticoagulants / therapeutic use
-
Blood Coagulation / drug effects
-
Ceftriaxone / therapeutic use
-
Drug Therapy, Combination
-
Humans
-
Inflammation Mediators / metabolism
-
Lipoproteins / therapeutic use*
-
Pneumonia, Pneumococcal / blood
-
Pneumonia, Pneumococcal / drug therapy*
-
Pneumonia, Pneumococcal / immunology
-
Pneumonia, Pneumococcal / microbiology
-
Recombinant Proteins / therapeutic use
-
Streptococcus pneumoniae / drug effects
-
Streptococcus pneumoniae / growth & development
Substances
-
Anti-Infective Agents
-
Anti-Inflammatory Agents
-
Anticoagulants
-
Inflammation Mediators
-
Lipoproteins
-
Recombinant Proteins
-
lipoprotein-associated coagulation inhibitor
-
Ceftriaxone